Status:
COMPLETED
Assessment of the Efficacy of Stereotactic Intracavitary Instillation of 90Yttrium Colloid
Lead Sponsor:
David Clarke
Collaborating Sponsors:
Nova Scotia Health Authority
Conditions:
Neuroepithelial Cyst
Eligibility:
All Genders
17+ years
Phase:
NA
Brief Summary
Neuroepithelial cysts are rare, representing less than 1% of the intracranial cysts. Neuroepithelial cysts, are benign and mostly asymptomatic. These cysts are lined by thin columnar or low cuboidal e...
Detailed Description
In brief, a single patient has been identified as having a cystic tumor by diagnostic imaging and clinical expertise and based on standards of excellence in clinical care will be offered participation...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Cystic tumor
- Required treatment
- Adult over 17 years of age
- Willingness to provide informed consent
- Exclusion criteria
- Solid tumor
- Treatment not required
- Child under 17 years of age
- Not willing to provide informed consent
Exclusion
Key Trial Info
Start Date :
March 23 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 24 2022
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT04758104
Start Date
March 23 2021
End Date
January 24 2022
Last Update
January 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nova Scotia Health Authority
Halifax, Nova Scotia, Canada, B3H 3A7